Menu
Neuropharmagen® was developed
and released to the market by AB-BIOTICS
AB-Biotics was founded in 2004 as one of the divisions of the Autonomous University of Barcelona (AUB). Today, we are leaders in the field of biotechnology, having received worldwide recognition. Our activities are divided into two main business areas (probiotics and personalized medicine), based on research, development, intellectual property and distribution of our own unique biotechnologies through international distributors and directly to consumers at the level of individual countries.
The company’s activities are concentrated around two areas:
- PRECISION MEDICINE: To improve the effectiveness of treatment in the field of psychiatry.
- PROBIOTICS: Provide a link between the microbiota pathology and the mechanism of action, this is a key element for the innovative development and patenting of strains from the unique collection of the AB-Biotics company.
We have a team of highly qualified specialists from various fields, including biotechnology, biochemistry, pharmaceuticals, genetics, microbiology and others.
All our specialists work together to solve all the tasks set in research, development and business.
